Companion Animal Health Announces Strategic Investment in Early Cancer Detection Solution

NEW CASTLE, Del.–(BUSINESS WIRE)–Companion Animal Health, a global animal health company specializing in laser and rehabilitation therapies and on-site diagnostics in veterinary markets worldwide, and a division of DJO, today announced a strategic agreement, including an equity investment, with HT BioImaging as a co-brand and exclusively sell the HTVet product in the United States and Canada. HTVet enables real-time, non-invasive diagnosis of suspicious skin and subcutaneous masses at the point of care. HTVet provides accurate results in minutes, enabling simple and accurate in-clinic testing without the need for labor-intensive, invasive procedures and external first-line labs.

At the heart of HTVet’s innovative technology is Heat Diffusion Imaging (HDI), an AI-based algorithm that recognizes cancer cells by their unique dynamic heat flux properties. The IDH allows the early detection of cancer and the classification of suspicious masses. The HTVet is a game changer that allows veterinarians to classify and detect cancer earlier.

Craig Tockman, president of Companion Animal Health, said, “Cancer is the cause of death in 47% of dogs and 32% of cats over the age of 10. Most deaths are due to late detection and misdiagnosis. HTVet helps veterinarians identify cancer early, dramatically improving survival rates for many patients. Early detection is key to saving lives. HTVet is a cost-effective, safe and accurate tool for cancer detection and fits perfectly into Companion’s broader mission to support the continuum of cancer care.

“HTVet enables Companion to offer an innovative solution in the field of veterinary oncology,” said Terry Ross, president of Recovery Sciences for DJO. “The Companion portfolio is centered on empowering the veterinarian to provide broader diagnostic and treatment options at the point of care. Together with HTVet, we will help veterinarians provide an essential and vital service to their pet owners and deliver on the Companion Promise.

HTVet is another addition to Companion’s portfolio of laser and regenerative therapies and on-site diagnostic solutions. HTVet will launch with a new co-branded name and will be available for sale later this year.

About pet health

Companion Animal Health provides veterinarians with the most advanced technologies in pain management, photobiomodulation, rehabilitation, regenerative therapies and diagnostics. Whether your goals are to heal and reduce pain, regenerate and repair tissue, diagnose and record treatment success, or provide rehabilitation modalities, Companion offers a portfolio of proven solutions for veterinary hospitals and their patients.

Companion’s products are backed by evidence, backed by education, and successfully implemented through Companion’s industry-leading commitment to long-term partnership. Learn more at https://companionanimalhealth.com/.

Companion is a division of DJO, a leading developer and marketer of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management.

About HT BioImaging

HT BioImaging is an Israel-based company that aims to save the lives of people and animals through the early detection of cancer. Its revolutionary patented medical imaging technology, heat diffusion imaging, was developed by a team of experts in the fields of AI, signal analysis and computer vision, in collaboration with high level researchers, oncologists and radiologists in heat transfer and thermodynamics. Learn more at https://www.htbioimaging.com/.

Boyd S. Abbott